Adults 18 to 85, any sex, with Brain Injuries. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Serial Reaction Time Task (SRTT) PerformancePrimary· Pre-test (baseline), Post-test (training usually lasts for 3 hours), Retention Test (30 mins following training)
The SRTT involves pressing a key that corresponds to a target square presented on a monitor. Sequenced skill (SS) is calculated by subtracting the response time of sequenced key presses from random key presses within and across a test block. An increase in SS value indicates an increase in sequenced skill and is a preferable result.
SS Pre-test
Group
Value
95% CI
Sham TMS
31
± 38
TMS Over Primary Motor Cortex (M1)
35
± 19
TMS Over Premotor Cortex (PMC)
38
± 24
SS Post-test
Group
Value
95% CI
Sham TMS
24
± 21
TMS Over Primary Motor Cortex (M1)
30
± 22
TMS Over Premotor Cortex (PMC)
17
± 23
SS Retention Testing
Group
Value
95% CI
Sham TMS
31
± 25
TMS Over Primary Motor Cortex (M1)
40
± 23
TMS Over Premotor Cortex (PMC)
29
± 11
Cortical Excitability Measured by Motor Evoked Potentials (MEPs)Secondary· Pre-test (baseline), Post-test (training usually lasts for 3 hours)
Evaluate the effect of sequence learning on motor cortical excitability. Cortical excitability will be indexed by peak-to-peak amplitudes of transcranial magnetic stimulation (TMS)-evoked electromyographic responses in the hand contralateral to the motor cortex targeted by TMS quantified before and after training. An increase in MEPs indicates neural plasticity due to increases in skill.
MEP Amplitude Pre-test
Group
Value
95% CI
Sham TMS
1.03
± 0.97
TMS Over Primary Motor Cortex (M1)
1.29
± 1.22
TMS Over Premotor Cortex (PMC)
0.45
± 0.37
MEP Amplitude Post-test
Group
Value
95% CI
Sham TMS
1.15
± 1.03
TMS Over Primary Motor Cortex (M1)
1.37
± 1.24
TMS Over Premotor Cortex (PMC)
0.51
± 0.53
Sponsor's own description
The long-term objective initiated with this study is to determine which brain areas functionally contribute to learning a motor skill. The primary hypothesis of this trial is that premotor cortex (PMC) is necessary to learn a new motor skill. Participants may undergo a MRI scan to acquire a structural image of their brain to target noninvasive stimulation, using transcranial magnetic stimulation (TMS) to one of two brain areas: PMC or primary motor cortex (M1). A third group of individuals will undergo a placebo stimulation protocol. For all three groups, stimulation will be used to create a transient 'virtual lesion' during motor skill training. Temporarily disrupting the normal activity of these brain regions during training will allow us to determine which regions are causally involved in learning a new motor skill. The primary outcome measure will be the change in skill after training in each group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Other trials of Transcranial Magnetic Stimulation (TMS)
Trials testing the same drug.
NCT05861284 — Developing and Optimizing Transcranial Magnetic Stimulation for Motor Rehabilitation
· NA
· withdrawn
NCT07250464 — Motor Evoked Potential and Cortical Silent Period in Migraine
· NA
· not yet recruiting
NCT07110493 — Study of Visual Perception Phenomena: Phosphene Mapping Induced by TMS and Its Relationship With Eye Movements
· NA
· recruiting
NCT06960083 — Transcranial Magnetic Stimulation in Misophonia
· NA
· recruiting
NCT07179406 — The Effect of Spinal Cord Stimulators on Restless Leg Syndrome
· NA
· recruiting
Other recruiting trials for Brain Injuries
Currently open trials in the same condition.
NCT06607523 — The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms
· NA
· recruiting
NCT06873477 — Evaluation of Patients Affected by Traumatic and Hypoxic-ischemic Brain Injury
· recruiting
NCT06511804 — Correlation Between Noninvasive Blood Vessel Functionality Parameters and Cerebral Hemodynamics in Neurocritical Care Pa
· recruiting
NCT06863025 — Effects of Neurofeedback Training on Attentional Deficits in Patients With Acquired Brain Injury
· NA
· active not recruiting
NCT06571032 — Electroencephalography in the Management of Neuroelectric Stimulation in Patients With Severe Traumatic Brain Injuries
· recruiting
Other Emory University trials
Trials by the same sponsor.
NCT06143345 — HIIT in Isolated IFG: A Proof-of-Concept Study
· NA
· withdrawn
NCT07189819 — Innovative Closed-loop Functional Electrical Stimulation Control System for Augmenting Post-stroke Gait
· NA
· not yet recruiting
NCT06451055 — Low-calorie Diet in Isolated Impaired Fasting Glucose
· NA
· not yet recruiting
NCT07405476 — Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative I
· Phase 2
· recruiting
NCT06708351 — Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Emory University
Last refreshed: 28 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04138953.